Not available
Quote | Trevena Inc. (NASDAQ:TRVN)
Last: | $0.40 |
---|---|
Change Percent: | -2.2% |
Open: | $0.3978 |
Close: | $0.409 |
High: | $0.409 |
Low: | $0.3978 |
Volume: | 3,110 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
News | Trevena Inc. (NASDAQ:TRVN)
2024-04-02 07:15:05 ET JMP Securities analyst issues MARKET OUTPERFORM recommendation for TRVN on April 2, 2024 05:40AM ET. The previous analyst recommendation was Market Outperform. TRVN was trading at $0.4 at issue of the analyst recommendation. Historical Analyst Re...
TRV045, novel S1P receptor modulator for chronic pain and epilepsy, advances toward important milestones in both non-clinical and clinical studies Company announces reduction of OLINVYK commercial support and review of alternatives for OLINVYK CHESTERBROOK, Pa., April 01, 2024 (GL...
Message Board Posts | Trevena Inc. (NASDAQ:TRVN)
Subject | By | Source | When |
---|---|---|---|
Guess I hit that On The Money Whooza | Triple nickle | investorshub | 05/08/2023 5:51:03 PM |
$TRVN: It's QUIET here because the iHub PUNDITS | Invest-in-America | investorshub | 05/08/2023 5:36:44 PM |
Damn! pretty quiet here considering what's going on. | madras50 | investorshub | 05/08/2023 5:15:19 PM |
https://stockcharts.com/h-sc/ui?s=trvn&p=D&yr=0&mn=6&dy=0&id=p38090673899 | surf1944 | investorshub | 05/08/2023 4:34:43 PM |
This is what $LILM is gonna do too ;) | LowFloatLopes | investorshub | 05/08/2023 3:56:07 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-04-02 07:15:05 ET JMP Securities analyst issues MARKET OUTPERFORM recommendation for TRVN on April 2, 2024 05:40AM ET. The previous analyst recommendation was Market Outperform. TRVN was trading at $0.4 at issue of the analyst recommendation. Historical Analyst Re...
TRV045, novel S1P receptor modulator for chronic pain and epilepsy, advances toward important milestones in both non-clinical and clinical studies Company announces reduction of OLINVYK commercial support and review of alternatives for OLINVYK CHESTERBROOK, Pa., April 01, 2024 (GL...
CHESTERBROOK, Pa., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Trevena, Inc. ("Trevena" or the "Company") (NASDAQ:TRVN), a biopharmaceutical company focus...